MacLean Hall
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 12
- Immunology 14
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 3
- Co-authors
- Amod A. Sarnaik (12 shared papers)Shari Pilon‐Thomas (16 shared papers)Vernon K. Sondak (2 shared papers)Jeffrey S. Weber (6 shared papers)Jane L. Messina (1 shared paper)Keiran S.M. Smalley (1 shared paper)Inna V. Fedorenko (1 shared paper)Kim H.T. Paraiso (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)Molecular Therapy (1 paper)British Journal of Cancer (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
MacLean Hall
19 papers receiving 805 citations
Peers
Comparison fields: 5 of 55
- Oncology 637
- Immunology 399
- Molecular Biology 307
- Computational Theory and Mathematics 56
- Biotechnology 23
Countries citing papers authored by MacLean Hall
This map shows the geographic impact of MacLean Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MacLean Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MacLean Hall more than expected).
Fields of papers citing papers by MacLean Hall
This network shows the impact of papers produced by MacLean Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MacLean Hall. The network helps show where MacLean Hall may publish in the future.
Co-authors
The 25 scholars most cited alongside MacLean Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 227 | |
| 2 | 2010 | 157 | |
| 3 | 2016 | 116 | |
| 4 | 2012 | 86 | |
| 5 | 2018 | 75 | |
| 6 | 2018 | 35 | |
| 7 | 2021 | 34 | |
| 8 | 2020 | 30 | |
| 9 | 2021 | 26 | |
| 10 | 2020 | 8 | |
| 11 | 2011 | 4 | |
| 12 | 2017 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2012 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 0 |
About MacLean Hall
MacLean Hall is a scholar working on Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 21 papers that have together received 811 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (3 papers), Melanoma and MAPK Pathways (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), CNS Lymphoma Diagnosis and Treatment (1 paper) and Colorectal and Anal Carcinomas (1 paper). The work is most often cited by research in Oncology (637 citations), Immunology (399 citations), Molecular Biology (307 citations), Computational Theory and Mathematics (56 citations) and Biotechnology (23 citations). MacLean Hall has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Amod A. Sarnaik, Shari Pilon‐Thomas, Vernon K. Sondak, Jeffrey S. Weber, Jane L. Messina, Keiran S.M. Smalley, Inna V. Fedorenko, Kim H.T. Paraiso, Liliana Cantini and Keith T. Flaherty. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Molecular Therapy, British Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.